Crimson clues: advancing endometriosis detection and management with novel blood biomarkers
Endometriosis is an inflammatory condition affecting approximately 10% of the female-born population. Despite its prevalence, the lack of noninvasive biomarkers has contributed to an established global diagnostic delay. The intricate pathophysiology of this enigmatic disease may leave signatures in the blood, which, when detected, can be used as noninvasive biomarkers. This review provides an update on how investigators are utilizing the established disease pathways and innovative methodologies, including genome-wide association studies, next-generation sequencing, and machine learning, to unravel the clues left in the blood to develop blood biomarkers.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tatjana Gibbons, Nilufer Rahmioglu, Krina T. Zondervan, Christian M. Becker Tags: Views and reviews Source Type: research
More News: Endometriosis | Learning | Reproduction Medicine | Study | Universities & Medical Training